Insider Transactions in Q2 2024 at Amneal Pharmaceuticals, Inc. (AMRX)
Insider Transaction List (Q2 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 17
2024
|
Deborah M. Autor Director |
SELL
Open market or private sale
|
Direct |
23,447
-20.07%
|
$140,682
$6.73 P/Share
|
|
May 16
2024
|
Deborah M. Autor Director |
SELL
Open market or private sale
|
Direct |
14,553
-11.08%
|
$87,318
$6.76 P/Share
|
|
May 10
2024
|
Deborah M. Autor Director |
BUY
Exercise of conversion of derivative security
|
Direct |
76,453
+36.78%
|
-
|
|
May 10
2024
|
Emily Peterson Alva Director |
BUY
Exercise of conversion of derivative security
|
Direct |
76,453
+23.36%
|
-
|
|
May 10
2024
|
Shlomo Yanai Director |
BUY
Exercise of conversion of derivative security
|
Direct |
76,453
+23.73%
|
-
|
|
May 10
2024
|
Ted C Nark Director |
BUY
Exercise of conversion of derivative security
|
Direct |
76,453
+20.27%
|
-
|
|
May 10
2024
|
J Kevin Buchi Director |
BUY
Exercise of conversion of derivative security
|
Direct |
76,453
+22.58%
|
-
|
|
May 10
2024
|
Jeffrey P. George Director |
BUY
Exercise of conversion of derivative security
|
Direct |
76,453
+22.1%
|
-
|
|
May 10
2024
|
John Kiely Director |
BUY
Exercise of conversion of derivative security
|
Direct |
76,453
+23.02%
|
-
|
|
May 10
2024
|
Paul M Meister Director |
BUY
Exercise of conversion of derivative security
|
Direct |
107,034
+12.82%
|
-
|
|
May 10
2024
|
Gautam Patel Director |
BUY
Exercise of conversion of derivative security
|
Direct |
76,453
+3.6%
|
-
|